Muyldermans S - Search Results

1

Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination.

Patris S, De Pauw P, Vandeput M, Huet J, Van Antwerpen P, Muyldermans S, Kauffmann JM. Patris S, et al. Among authors: muyldermans s. Talanta. 2014 Dec;130:164-70. doi: 10.1016/j.talanta.2014.06.069. Epub 2014 Jul 7. Talanta. 2014. PMID: 25159394

2

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer.

Vaneycken I, Devoogdt N, Van Gassen N, Vincke C, Xavier C, Wernery U, Muyldermans S, Lahoutte T, Caveliers V. Vaneycken I, et al. Among authors: muyldermans s. FASEB J. 2011 Jul;25(7):2433-46. doi: 10.1096/fj.10-180331. Epub 2011 Apr 8. FASEB J. 2011. PMID: 21478264

3

Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 Nanobodies for iPET imaging of HER2 receptor expression in cancer.

Xavier C, Vaneycken I, D'huyvetter M, Heemskerk J, Keyaerts M, Vincke C, Devoogdt N, Muyldermans S, Lahoutte T, Caveliers V. Xavier C, et al. Among authors: muyldermans s. J Nucl Med. 2013 May;54(5):776-84. doi: 10.2967/jnumed.112.111021. Epub 2013 Mar 13. J Nucl Med. 2013. PMID: 23487015 Free article.

4

Nanobodies and their potential applications.

Hassanzadeh-Ghassabeh G, Devoogdt N, De Pauw P, Vincke C, Muyldermans S. Hassanzadeh-Ghassabeh G, et al. Among authors: muyldermans s. Nanomedicine (Lond). 2013 Jun;8(6):1013-26. doi: 10.2217/nnm.13.86. Nanomedicine (Lond). 2013. PMID: 23730699

5

Site-specific labeling of cysteine-tagged camelid single-domain antibody-fragments for use in molecular imaging.

Massa S, Xavier C, De Vos J, Caveliers V, Lahoutte T, Muyldermans S, Devoogdt N. Massa S, et al. Among authors: muyldermans s. Bioconjug Chem. 2014 May 21;25(5):979-88. doi: 10.1021/bc500111t. Epub 2014 May 9. Bioconjug Chem. 2014. PMID: 24815083

6

Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.

Romao E, Morales-Yanez F, Hu Y, Crauwels M, De Pauw P, Hassanzadeh GG, Devoogdt N, Ackaert C, Vincke C, Muyldermans S. Romao E, et al. Among authors: muyldermans s. Curr Pharm Des. 2016;22(43):6500-6518. doi: 10.2174/1381612822666160923114417. Curr Pharm Des. 2016. PMID: 27669966 Review.

7

Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization.

Gevenois PJY, De Pauw P, Schoonooghe S, Delporte C, Sebti T, Amighi K, Muyldermans S, Wauthoz N. Gevenois PJY, et al. Among authors: muyldermans s. J Immunol. 2021 Nov 15;207(10):2608-2620. doi: 10.4049/jimmunol.2100250. Epub 2021 Oct 13. J Immunol. 2021. PMID: 34645688

8

Bacterial two hybrid: a versatile one-step intracellular selection method.

Pellis M, Muyldermans S, Vincke C. Pellis M, et al. Among authors: muyldermans s. Methods Mol Biol. 2012;911:135-50. doi: 10.1007/978-1-61779-968-6_9. Methods Mol Biol. 2012. PMID: 22886250

9

Nanobody-based chromatin immunoprecipitation.

Duc TN, Hassanzadeh-Ghassabeh G, Saerens D, Peeters E, Charlier D, Muyldermans S. Duc TN, et al. Among authors: muyldermans s. Methods Mol Biol. 2012;911:491-505. doi: 10.1007/978-1-61779-968-6_31. Methods Mol Biol. 2012. PMID: 22886272

10

Nanobody(R)-based chromatin immunoprecipitation/micro-array analysis for genome-wide identification of transcription factor DNA binding sites.

Nguyen-Duc T, Peeters E, Muyldermans S, Charlier D, Hassanzadeh-Ghassabeh G. Nguyen-Duc T, et al. Among authors: muyldermans s. Nucleic Acids Res. 2013 Mar 1;41(5):e59. doi: 10.1093/nar/gks1342. Epub 2012 Dec 28. Nucleic Acids Res. 2013. PMID: 23275538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

292 results

Search Page

Filters